BEIJING-ZHENWEI
30.3.2016 09:02:01 CEST | Business Wire | Press release
The 5th Beijing International Import Food Expo 2016 (cipfe 2016) will take place on 6th -8th May, 2016 at Beijing Exhibition Center. With an exhibition area of 20,000m2 , cipfe 2016 will present 10 pavilions covering leisure food (chocolates, candies, nuts and etc), coffee and tea, beverage, organic food, wines and beers, dairy, oil, meat, etc. Over 600 international food enterprises from more than 30 countries and regions are expected to attend the exhibition, including US, Italy, Spain, Australia, Thailand, South Korea and Malaysia.
Under the theme of “Share the Global Taste”, the organizers of the event, China Chamber of International Commerce (CCOIC) and Zhenwei Exhibition Group, will provide the biggest national-level imported food trade platform for over 32,000 visitors, including import-export traders, food distributors, supermarkets, hotels, restaurants, top clubs and other related industry sectors. As one of the highlights in the exhibition, numerous buyers will also seek potential consumers and enlarge their business cooperation in Asian market.
In order to attract the most influential targeted visitors during the three-day event, the diamond buyers invitation group of cipfe 2016 will identify valuable buyers and establish and maintain contact with them, so that the exhibitors can learn the latest ideas and thoughts of the attendees. Meanwhile, some seminars such as Products Promotion Seminar, Oversea Products Purchasing Seminar and World Delicacy Tasting Seminar will be concurrently held during the exhibition.
Besides, over 100 mainstream media like People’s Daily, CCTV, Xinhua, China Daily, Beijing TV Station, sina.com.cn, ifeng.com, sohu.com, China Taiwan and Asia Food will attend the event and offer the latest industry information and investment opportunities for visitors and buyers worldwide. Furthermore, Business Recruitment Agency Conference, World Food Tasting Conference and Networking of Shop, Supermarket and E-commerce will also create great chances for both traders and buyers to learn the development trend of the food industry and make long-term win-win collaborations.
More information about cipfe 2016, please visit: www.cipfe.com .
About cipfe
Beijing International Import Food Expo (cipfe) is the only one National-level import food expo in Beijing. The CCOIC and Zhenwei will build a famous Brand Exhibition Project, and make full use of the 200,000 professional database, which include the international buyers in China, Food agencies, Supermarket, High-end club etc.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160330005027/en/
Contact:
Beijing Zhenwei Exhibition Co., Ltd.
Margaret Duan or Cassidy Liu,
+8613910314389, +86-10-58236512
cipfe@zhenweiexpo.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release
FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 16:13:00 CEST | Press release
In a head-to-head benchmark, a leading general-purpose LLM was confidently wrong 35% of the time on regulatory dates. Archer Evolv™ shipped zero errors. For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and mo
Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 16:08:00 CEST | Press release
Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d
Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS30.6.2026 16:00:00 CEST | Press release
IB SmartRouting℠ Routes Orders to the Best Available Price Between KRX and Nextrade Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and access to additional liquidity. Interactive Brokers has enabled IB SmartRouting℠ across both the Korea Exchange (KRX) and Nextrade, automatically routing orders to the venue offering the best price. This helps clients achieve best execution while providing greater flexibility and more opportunities to participate in one of Asia's most dynamic equity markets. Korea's equity market ranks among the top global exchanges by
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom